Fortitude Family Office, LLC Bio N Tech Se Transaction History
Fortitude Family Office, LLC
- $280 Billion
- Q4 2024
A detailed history of Fortitude Family Office, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Fortitude Family Office, LLC holds 15 shares of BNTX stock, worth $1,793. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15Holding current value
$1,793% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$983 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$527 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$514 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$227 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$216 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...